Gregory Lip, MD, is Price-Evans Chair of Cardiovascular Medicine, and Director of the Liverpool Centre for Cardiovascular Science at the University of Liverpool and Liverpool Heart & Chest Hospital. He is a NIHR Senior Investigator. He was conferred as Distinguished Professor at Aalborg University, Denmark; and is an Adjunct Professor, Yonsei University, Seoul, Korea. Half of his time is spent as a clinical cardiologist, including outpatient specialist clinical services in atrial fibrillation and hypertension, and managing acute cardiology patients.

Professor Lip has a major personal interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research, and are now incorporated into most international guidelines.

His current group’s research interests are broad, ranging from epidemiology to pathophysiology, translational research, clinical risk assessment and trajectories of risk, patient management pathways, and applied health research. He is passionate about using ‘big data’ and epidemiological observations to generate hypotheses and to inform clinical studies that help improve the management of common cardiovascular conditions, such as atrial fibrillation, hypertension and thrombosis.

This ‘big data’ work is often in collaboration with an extensive global network of friends and collaborators, including those in Denmark, France, the Balkans, Taiwan, Korea and Japan, sharing a common goal in ‘research without boundaries’ in relation to epidemiology and clinical studies.

https://www.rcpe.ac.uk/college/professor-gregory-lip